May 28, 2025

šŸŽ„ HaysMed performs first pulse field ablation procedure

Posted May 28, 2025 9:45 AM
Photo includes front row from left to right: Carmen Keller, HaysMed CVOR/Cath Lab Manager, Dr. Jacob Morgan HaysMed Electrophysiology Cardiologist, and Autumn Robbins, RN HaysMed Cath Lab. Back row left to right: Neal Hanson Afib Solutions Territory Manager Boston Scientific Corporation, Justin Baalmann Cardiac Rhythm Management Territory Manager Boston Scientific Corporation, Daniel Cooper Afib Solutions Mapping Specialist Boston Scientific Corporation, and Carly Leiker HaysMed CV Lab Technologist. Photo by HaysMed
Photo includes front row from left to right: Carmen Keller, HaysMed CVOR/Cath Lab Manager, Dr. Jacob Morgan HaysMed Electrophysiology Cardiologist, and Autumn Robbins, RN HaysMed Cath Lab. Back row left to right: Neal Hanson Afib Solutions Territory Manager Boston Scientific Corporation, Justin Baalmann Cardiac Rhythm Management Territory Manager Boston Scientific Corporation, Daniel Cooper Afib Solutions Mapping Specialist Boston Scientific Corporation, and Carly Leiker HaysMed CV Lab Technologist. Photo by HaysMed

HaysMed

HaysMed proudly announces the successful completion of its first Pulse Field Ablation (PFA) procedure, performed on May 14, 2025, by Dr. Jacob Morgan, electrophysiologist and cardiologist, in collaboration with the HaysMed Catheterization Laboratory team.

This milestone marks a significant advancement in cardiac care for the region, as HaysMed becomes one of the first facilities in western Kansas to utilize the FARAPULSEā„¢ Pulsed Field Ablation System- a newly FDA-approved technology for the treatment of atrial fibrillation (AFib).

PFA represents a next-generation approach to cardiac ablation. Unlike traditional thermal ablation methods that use extreme heat or cold to destroy problematic heart tissue, the FARAPULSE system employs non-thermal, tissue-selective electric fields. This innovation minimizes the risk of damage to surrounding structures while maintaining high efficacy in treating AFib.

ā€œPatients are increasingly aware of new treatment options like PFA,ā€ said Dr. Morgan. ā€œWe are pleased to offer this cutting-edge technology to our community. The incidence of atrial fibrillation continues to rise, and having access to safer, faster, and more effective therapies allows us to improve outcomes and expand care to more patients.ā€

According to Boston Scientific, the FARAPULSE PFA System has demonstrated comparable effectiveness to traditional radiofrequency ablation, with added benefits of reduced procedure time and enhanced safety. The system has been used successfully worldwide and is now available in the U.S. following regulatory approval.

ā€œIntroducing this technology at HaysMed is a major step forward for cardiac care in our region,ā€ Dr. Morgan added. ā€œWe are excited to bring this innovation to patients in Hays and across western Kansas.ā€

To learn more about how the FARAPULSE PFA System works, including a visual overview of the procedure, please watch the video provided by Boston Scientific: Deep Dive into FARAPULSEā„¢: PFA System Workflow Animation below.

local